20 employees
Biodel is a biopharmaceutical company developing and commercializing therapeutics for the treatment of diabetes.
2003
$30M
from 2 investors over 2 rounds
Biodel Inc. raised $30M on May 13, 2011
Investors: Great Point Partners and OrbiMed Advisors